Emergency Department Venous Thrombo-Embolism Guideline

 
CONTINUE READING
Emergency Department Venous Thrombo-
         Embolism Guideline
Reference:      1940v1
Written by:     Dr L Hickinbotham, D G Hartshorne, Dr J Gilchrist
Peer reviewer: Jeanette Payne
Approved:       February 2020
Review Due:     October 2022

Purpose
This guideline is designed as a quick reference guide for use in acute presentation
and not to replace the detailed guidelines found linked within this document.

Acute Venous Thrombosis CG1333 4

http://staff.sch.nhs.uk/documents/12-ward-6/148-acute-venous-thrombosis-m3-patients

Intended Audience
This guideline is for use by all clinical staff managing patients presenting acutely with
potential venous thromboembolism

                                                                                   Page 1 of 5
CAEC Registration Identifier 1940                        Sheffield Children’s NHS Foundation Trust
                                       Venous Thrombo-Embolism Guideline

        Contents
        A. BACKGROUND
        B. ASSESSMENT
        C. INVESTIGATIONS
        D. MANAGEMENT

        A.       Background
                 VTE in children is something that remains a rare presentation (approximately
                 58 per 10,000 hospital admissions 1) but can have significant consequences
                 when not identified and treated.

                 The aim of the guideline is to aid in the assessment and management of
                 patients presenting with symptoms suggestive of VTE and the subsequent
                 management.

                 Differential diagnoses to consider include:
                     o Pulmonary Embolism
                             Pneumonia
                             Sepsis
                             Congenital heart disease

                     o   Deep vein thrombosis
                            Vasculitis and thrombophlebitis
                            Trauma
                            Cellulitis

             B. Assessment
                Assessing the patient requires an initial high degree of suspicion and history
                taking and examination needs to be focussed once symptoms suggestive of
                VTE are recognised.

                 Symptoms can range from the clinically stable patient with subtle signs to
                 being overtly unwell and peri-arrest.

                 Pulmonary Embolism – chest pain, shortness of breath, anxiety, light-
                 headedness.

                 Deep vein thrombosis - unilateral limb swelling and pain without history of
                 trauma.

                 Examination findings may include:

                 PE - Apprehension, sweaty/clammy, tachycardia, tachypnoea, hypotension,
                 hypoxia. If any of the latter signs are present senior involvement and moving
                 the patient to resus is recommended.
                        (Haemoptysis is seldom present in children but can be a sign in
                        adolescents or adults.)

                 DVT - Leg or arm oedema,             erythema,    increased      warmth,     palpable
                 cord/vessel, tenderness.

Dr L Hickinbotham, D G Hartshorne, Dr J Gilchrist                        Review date: Oct 2022
© SC(NHS)FT 2020. Not for use outside the Trust.                                    Page 2 of 5
CAEC Registration Identifier 1940                        Sheffield Children’s NHS Foundation Trust
                                       Venous Thrombo-Embolism Guideline

                 VTE is thought to be multifactorial in the adolescent population 2 and so
                 history taking should include looking for risk factors (see table 1) when VTE is
                 thought to be a possibility.

        TABLE 1

        RISK FACTORS                                     HYPERCOAGULABLE STATE

        Immobilization                                   SLE (Lupus)

        Travel (≥ 4 hours in past 1 month)               Connective tissue disorders

        Surgery (within past 3 months)                   Nephrotic syndrome

        Pregnancy (current or recent)                    Factor V Leiden Mutation

        OCP & Oestrogen replacement (including soon      Protein C, S Deficiency
        after commencement)

        Malignancy                                       Antithrombin Deficiency

        Tobacco Use                                      Inflammatory bowel disease

        Haemolytic anaemias (Sickle cell)                Hyperlipidaemias

        Central Venous Instrumentation < 3mo             Homocysteinaemia, homocystinuria

        Central Venous Catheters

        Intravenous Drug Use                             MEDICATIONS

        Stroke, paresis, paralysis                       Warfarin within days of initiation

        Heart failure                                    Phenothiazines

        Varicose Veins & Thrombophlebitis

        Trauma: Lower Ext, Pelvis < 3 month              Family history of VTE in a close relative especially
                                                         at a young age

            C. Investigations

                 Laboratory investigation of VTE (such as D-dimer) are not validated in
                 children as the value may vary with age, therefore making it difficult to
                 interpret. Further information can be found on the guideline (D-Dimers* in the
                 Investigation of Venous Thromboembolism) available on the intranet 5.

                 http://staff.sch.nhs.uk/documents/24-medicine-handbook/1220-d-dimers-in-the-
                 diagnosis-of-venous-thromboembolism

                 In a post pubertal child who does not have active malignancy, a central line,
                 known thrombophilia, strong family history of VTE or nephrotic syndrome with
                 a pulmonary embolism rule-out criteria (PERC) score of zero then the risk of
                 PE is very low (
CAEC Registration Identifier 1940                        Sheffield Children’s NHS Foundation Trust
                                       Venous Thrombo-Embolism Guideline

                             PERC criteria:
                                - heart rate >100 beats per minute
                                - peripheral oxygen saturations 2 hours from presentation to
                 imaging then the first dose of Low-Molecular Weight Heparin should be
                 administered prior to referral.

                 In SC(NHS)FT enoxaparin (Clexane) is used, so to avoid confusion doses are only
                 quoted for enoxaparin.

                 Dosing for enoxaparin (Clexane)

                                               Age 2 months
                  Initial treatment     1.5mg/kg/dose 12hrly sub-     1mg/kg/dose 12hrly sub-
                         dose                 cutaneously.                   cutaneously
                                         Round the dose to the next full 1mg

                 Full guidance can be found on the guideline: Heparin (CG1020) 6.

                 http://staff.sch.nhs.uk/documents/12-ward-6/11-heparin-guideline-m3-patients

Dr L Hickinbotham, D G Hartshorne, Dr J Gilchrist                         Review date: Oct 2022
© SC(NHS)FT 2020. Not for use outside the Trust.                                     Page 4 of 5
CAEC Registration Identifier 1940                        Sheffield Children’s NHS Foundation Trust
                                       Venous Thrombo-Embolism Guideline

                 A confirmed VTE requires anti-coagulation initially with LMWH before
                 commencing vitamin K antagonist (warfarin). Detailed guidance on
                 commencing warfarin can be found in the guideline: Warfarin and other
                 outpatient anticoagulation (CG1010) 7. Referral to the on-call medical team
                 for in-patient management will be necessary.

                 http://staff.sch.nhs.uk/documents/12-ward-6/5-warfarin-and-other-outpatient-
                 anticoagulation-for-m3-patients

        References

            1. Pediatric      Thromboembolism.        Scott     C      Howard,     MD.
               https://emedicine.medscape.com/article/959501-overview#a4 [Accessed 15th
               June 2019]

            2. Risk factors and co-morbidities in adolescent thromboembolism are different
               than those in younger children. Thromb Res. 2016; 141:178-82 (ISSN: 1879-
               2472)

            3. BNFC [Accessed 2 July 2019]

            4. Acute Venous Thrombosis CG1333 http://staff.sch.nhs.uk/documents/12-
               ward-6/148-acute-venous-thrombosis-m3-patients [Accessed 19th July 2019]

            5. D-dimers       in    the   investigation of    Venous    Thromboembolism
               http://staff.sch.nhs.uk/documents/24-medicine-handbook/1220-d-dimers-in-
               the-diagnosis-of-venous-thromboembolism [Accessed 19th July 2019]

            6. Heparin (CG1020). http://staff.sch.nhs.uk/documents/12-ward-6/11-heparin-
               guideline-m3-patients [Accessed 19th July 2019]

            7. Warfarin        and     other    outpatient     anticoagulation    (CG1010)
               http://staff.sch.nhs.uk/documents/12-ward-6/5-warfarin-and-other-outpatient-
               anticoagulation-for-m3-patients [Accessed 19th July 2019]

         (Section written by Dr L Hickinbotham and D G Hartshorne Dr J Gilchrist, July 2019)

Dr L Hickinbotham, D G Hartshorne, Dr J Gilchrist                        Review date: Oct 2022
© SC(NHS)FT 2020. Not for use outside the Trust.                                    Page 5 of 5
You can also read